Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 2,500,000 shares, a drop of 10.7% from the March 31st total of 2,800,000 shares. Based on an average daily volume of 836,100 shares, […]
Motley Fool Asset Management LLC reduced its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 8.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,035 shares of the biopharmaceutical company’s stock after selling 196 shares during the period. Motley […]
StockNews.com Downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Hold theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Wellington Management Group LLP Purchases 364,021 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.